Both in Pharmaceuticals
LB Pharmaceuticals vs Opko Health
Over the past year LBRX returned +144.6% and OPK returned +10.2%; their daily moves had a correlation of 0.01.
LBRX +144.6% OPK +10.2%Growth of $1, one year, split-adjusted
| Metric | LBRX | OPK |
|---|---|---|
| Price | $37.28 | $1.62 |
| Market cap | $1.20B | $1.21B |
| Today | −1.61% | −0.61% |
| 1 month | −21.9% | +9.5% |
| 6 months | +60.3% | +47.3% |
| Year to date | +67.5% | +28.6% |
| 1 year | +141.5% | +11.7% |
| Revenue growth (YoY) | — | +4.3% |
| Gross margin | — | 48.9% |
| Net margin | — | −5.1% |
| P/E (TTM) | — | — |
| Price / sales | — | 2.1× |
| Net cash | $327.8M | -$46.5M |
| Dividend yield | — | — |
| Volatility (60d) | 58.1% | 84.1% |
| Short % of float | 23.9% | 9.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).